Pfizer, Merck strike deal to develop cancer tumor treatment

/ / Published in Capital Market News

Germany’s Merck will get $850 million upfront to work on the product, but Pfizer downgrades its 2014 EPS view as a result of the transaction.

Source : MarketWatchCom

What you can read next

60 Reforms Implemented To Diversify Nigeria’s Economy – Aganga
Slide Show: 10 of the prettiest towns in the U.S. where you can retire reasonably well
Turkish Airlines passengers to be prosecuted for security breach